Hepatoprotective Effect of Captopril on Liver Toxicity Induced by High and Low Dose of Paracetamol in Rats:Histological Study by Mudawi, Abdelhadi Y. A. Yassin, Rami S. Habeballa, Vijay R. Chidrawar, Turki M. Al-Shaikh, Mahmoud M. E.
Asian Journal of Pharmaceutical Research and Health Care, Vol 8(3), 92-99, 2016
ISSN (Online) : 2250-1460
DOI: 10.18311/ajprhc/2016/4412
* Author for correspondence
AbstractMany patients may administered medications like captopril (ACE inhibitor) for treatment of chronic diseases and may also take Paracetamol as an Over The Counter (OTC) drug which may interact with captopril. Therefore, the aim of this study is to evaluate of the hepatoprotective effect of captopril on liver toxicity induced by low and high dose of paracetamol in 
rats. This study was conducted in two phases: first study for low dose of paracetamol (300 mg/kg); animals were divided 
into 4 groups of 6 rats each (n = 6); all groups were treated orally either 0.9 % Normal Saline (NS), captopril 20 mg/kg, 
paracetamol 300 mg/kg or captopril 20 mg/kg plus paracetamol 300 mg/kg for 10 consecutive days. Second study for 
single high dose of paracetamol (3000 mg/kg); animals were divided into 4 groups of 6 rats each (n = 6); all groups were 
pretreated orally either 0.9 % Normal Saline (NS) or captopril 20 mg/kg for 7 consecutive days followed by single oral 
administration of Paracetamol 3000 mg/kg or normal saline. The administration of Paracetamol or normal saline was 
performed 24 hours after the last administration of captopril. After 48 hours of hepatic injury induction, the animals were 
then sacrificed and the liver was removed for histopathological studies. Low dose (300 mg/kg) for 10 days and high single 
dose (3000 mg/kg) of paracetamol produced hepatotoxic effects. While captopril 20 mg/kg showed marked protection against changes induced by low and high dose of paracetamol on the liver.
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Paracetamol (acetaminophen) is one of the most 
commonly used analgesic and antipyretic drugs1. 
It is a rapid, reversible, noncompetitive inhibitor of 
cyclooxygenase activity2. Paracetamol is widely used 
over the counter pain and fever reliever, and remains a 
major cause of overdose and overdose-related Acute 
Liver Failure (ALF) and death in the United States, united 
kingdom and many other countries like Saudi Arabia3,4. 
The World Health Organization estimates that total 
number of acute unintentional poisonings throughout 
the world ranges from 3.5-5.0 million cases annually, of 
which 3 million are severe poisonings resulting in 20 000 
deaths annually5,6. On the other hand, lack of knowledge 
of patients on Over The Counter (OTC) drugs lead to 
irrational use7.
Acetaminophen has long been recognized as 
potentially lethal because of dose-related hepatotoxicity 
and often nephrotoxicity2,8. It is reported that paracetamol 
can cause acute and chronic nephrotoxic effects9. 
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Acute toxicity after ingestion of large doses (10-15 g) is 
characterized by necrosis and damage to the proximal 
tubule. Chronic ingestion of much lower doses (500-1000 
mg) can produce renal damage9.
1.2 Captopril
Angiotensin Converting Enzyme inhibitors (ACE 
inhibitors) like captopril is widely used for treatment of 
hypertension and congestive heart failure10. They are used 
for long-term management of patients with congestive 
heart failure, as well as diabetic and non-diabetic 
nephropathies11.
Captopril contains active sulfhydryl group and shares 
other structural feature with cysteine which is the main 
substrate for glutathione
10
. According to a study published 
in the year 2000 the result showed that captopril was able 
to enhance total glutathione content as well as glutathione 
peroxidase and glutathione reductase activities in various 
mouse tissues
12
. While another study published in the 
year 2008 showed that captopril decreased the activity of 
both glutathione peroxidase and glutathione reductase13. 
However, Single doses of captopril given to rats produced 
a significant time dependent depletion of hepatic 
glutathione10.
2.  Background of the Study
Many patients may administered medications like 
captopril (ACE inhibitor) for treatment of chronic 
diseases and may also take Paracetamol as an Over The 
Counter (OTC) drug which may interact with captopril. 
Therefore, the aim of this study is to evaluate of the effects 
of captopril, low and high dose of Paracetamol on the 
liver of rats.
3.  Materials and Methods
3.1 Materials
3.1.1 Animals
Wistar rats weighing 200-250 g were used in this study. 
The animals were kept and maintained under laboratory 
conditions in the Faculty of Pharmacy, Northern Border 
University, KSA; and were allowed free access to food 
(standard pellet diet) and water ad libitum. The animals 
were divided into 8 groups of 6 animals.
3.1.2 Drugs
Captopril (Capoten®) and Paracetamol (Panadol®) were 
purchased from the local market in KSA.
3.2 Methods
3.2.1 Experimental Protocol
3.2.1.1 Low Dose Paracetamol (300 mg/kg)
Animals were divided into 4 groups of 6 rats each (n = 
6). All groups were treated orally either 0.9 % Normal 
Saline (NS), captopril 20 mg/kg, Paracetamol 300 mg/kg 
or captopril 20 mg/kg + paracetamol 300 mg/kg for 10 
consecutive days. The animals were then sacrificed and 
the liver was removed for histopathological studies.
Table 1.    Animal grouping and treatment schedule
Group Treatment
Group 1 Normal control group received normal saline
Group 2 Paracetamol control group 300 mg/kg
Group 3 Captopril 20 mg/kg
Group 4 Captopril 20 mg/kg + Paracetamol 300 mg/kg
3.2.1.2 High Dose Paracetamol (3000 mg/kg)
Animals were divided into 4 groups of 6 rats each (n = 
6). All groups were pretreated orally either 0.9 % Normal 
Saline (NS) or captopril 20 mg/kg for 7 consecutive days 
followed by single oral administration of Paracetamol 
3000 mg/kg or normal saline. The administration of 
Paracetamol or normal saline was performed 24 hours 
after the last administration of captopril. After 48 hours 
of hepatic injury induction, the animals were then 
sacrificed and the liver was removed for histopathological 
studies14,15.
Table 2.    Animal grouping and treatment schedule
Group Treatment
Group 1 Normal control group received normal saline
Group 2 Paracetamol control group 3000mg/kg
Group 3 Captopril 20 mg/kg
Group 4 Captopril 20 mg/kg + Paracetamol 3000mg/kg
3.2.2 Histological Study
The liver tissue was dissected out and fixed in 10% 
formalin. The tissues were processed and embedded in 
paraffin wax and sectioned. Sections were stained with 
Haematoxylin and Eosin (H&E) dye for microscopic 
observation of histological changes in the liver14,15.
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4.  Results
4.1  Histological Findings of the Liver (Low 
Dose Paracetamol and Captopril)
As shown in the figures; sections from rat liver stained by 
H&E demonstrated that the liver sections from normal 
control group treated with normal saline at Central 
Vein region (CV) hepatocytes showed lightly stained 
cytoplasm with rounded central euchromatic nuclei (thin 
black arrows). Cell plates are separated by thin wall blood 
sinusoids lined by flat endothelial cells (white arrows) 
(Figure 1). While the histopathological examination 
of the liver tissue of rats pre-treated with paracetamol 
300 mg/kg for 10 days showed marked congestion of 
Central Vein (CV). Hepatocytes (black dotted arrows) 
have darker cytoplasm, increased bi nucleation or dark 
enlarged nuclei (karyomegaly). In the second animal the 
cells looked shrunken and separated from each other 
or lost their outlines. Blood sinusoids are congested 
in some samples and Von Kupffer cell nuclei are more 
numerous and prominent (white arrows). Fibrous tissue 
proliferation could be seen around the veins and may be 
extend between lobules (stars) (Figure 2).
Liver sections from rats pre-treated with captopril 
20 mg/kg for 10 days demonstrated that the hepatocytes 
have more active euchromatic nuclei compared to control 
(black arrows). Sinusoids are infiltrated by mononuclear 
cells (white arrows) (Figure 3).
Figure 1.    Normal control group: sections from rat 
liver stained by H&E.
Figure 3.    Captopril 20 mg/kg group: sections from rat 
liver stained by H&E.
Figure 2.    Paracetamol 300 mg/kg group: sections from rat liver stained by H&E.
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Interestingly, the liver sections from rats pre-treated 
with captopril 20 mg/kg and paracetamol 300 mg/kg 
concomitantly for 10 days showed marked protection 
against changes induced by paracetamol. Hepatocytes 
(arrows) looked normal with active euchromatic nuclei 
similar or healthier than control. No congestion of blood 
vessels or sinusoids (white arrows) (Figure 4).
Figure 4.    Captopril 20 mg/kg + Paracetamol 300 mg/
kg group: sections from rat liver stained by H&E.
The figures shown in sections from rat liver at the 
portal region were branches of Bile Ducts (BD) and Portal 
Veins (PV) could be seen. Sections from normal control 
group treated with normal saline (G1) showed normal 
portal contents and nearby hepatocytes (arrows) (Figure 
5). The histopathological examination of the liver tissue 
of rats pre-treated with paracetamol 300 mg/kg for 10 
days (G2) showed shrunken hepatocyte cell cords with 
dark degenerated nuclei (black arrows). Blood sinusoids 
are slightly dilated and showed mononuclear cell infiltrate 
(white arrows). Portal region showed expansion, fibrosis 
and inflammatory cell infiltrate (stars) with signs of Bile 
Duct proliferations (BD), marked congestion of Portal 
Vein (PV) blood sinusoids (White arrows) and thickened 
Hepatic Artery (HA) and PV walls (thin black arrows) 
(Figure 6). Liver sections from rats pre-treated with 
captopril 20 mg/kg for 10 days (G3) showing slight or no 
changes in portal area, hepatocytes also looked normal 
(arrows) (Figure 7). The liver sections from rats pre-
treated with captopril 20 mg/kg and paracetamol 300 
mg/kg concomitantly for 10 days (G4) showed marked 
protection from paracetamol induced histological 
changes. Both portal elements and hepatocytes (arrows) 
looked more healthy than normal (Figure 8).
Figure 5.    Normal control group: sections from rat 
liver (portal region) stained by H&E.
Figure 6.    Paracetamol 300 mg/kg group: sections from rat liver (portal region) stained by H&E.
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Figure 7.    Captopril 20 mg/kg group: sections from rat 
liver (portal region) stained by H&E.
Figure 8.    Captopril 20 mg/kg +Paracetamol 300 mg/kg 
group: sections from rat liver (portal region) stained by 
H&E.
4.2  Histological Findings of the Liver 
(High Dose Paracetamol and 
Captopril)
Sections from rat liver stained by H&E showed the 
liver sections from normal control group (group 1) 
administered normal saline with normal Central Vein 
(CV) and hepatocyte cell cords (thin black arrows)
separated by thin non-congested sinusoids (white arrows) 
(Figure 9). The histopathological examination of the liver 
tissues of rats pre-treated with paracetamol 3000 mg/kg 
single dose (group 2) showing marked perivascular (CV) 
degeneration and necrosis (squares in inset). Complete 
loss of hepatocyte outlines (star) compared to non-
affected cells (black arrows) was noticed [Figure 10 (a)]. 
Marked necrosis of hepatocytes (arrows) and damage of 
bile ducts (thick black arrows) with inflammatory cell 
infiltrate (white stars and inset) was also observed [Figure 
10 (b)].
Liver sections from rats treated with captopril 20 
mg/kg (group 3) showing normal Central Vein (CV), 
hepatocytes cell cords (black arrows) and sinusoids (white 
arrows) (Figure 11). On the other hand the liver sections 
from rats treated with captopril 20 mg/kg and paracetamol 
3000 mg/kg (group 4) showed that the hepatocytes looked 
normal without any signs of degeneration or necrosis 
(black arrows). Congestion in some Central Veins (CV) 
but Sinusoids are thin wall and non-congested (Figure 
12).
Figure 9.    Normal control group: sections from rat 
liver stained by H&E.
Figure 10.    Paracetamol 3000 mg/kg group: sections from rat liver stained by H&E.
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Figure 11.    Captopril 20 mg/kg group: sections from 
rat liver stained by H&E.
Figure 12.    Captopril 20 mg/kg + Paracetamol 3000 
mg/kg group: sections from rat liver stained by H&E.
4.2.1 Portal Region
As shown in the figures sections from portal region 
showed branches of Bile Duct (BD) and Portal Vein (PV) 
of control group (group 1) with normal appearance, 
no dilation or congestion, hepatocytes looked normal 
(arrows) (Figure 13). The histopathological examination 
of the liver tissue of rats treated with paracetamol 3000 
mg/kg (group 2) showed dilation and congestion of Portal 
Vein (PV) and Bile Duct proliferation (BD) and slight 
perivascular fibrosis (star) (Figure 14). Liver sections 
from rat treated with captopril 20 mg/kg (group 3) 
showing slight congestion of Portal Vein (PV) normal Bile 
Duct (BD) and hepatocytes (arrows) (Figure 15). While 
the liver sections from rats pre-treated with captopril 20 
mg/kg and paracetamol 3000 mg/kg; showing marked 
protection with normal3 portal triad Portal vein (PV) 
slightly congested. Hepatic Artery (HA) and Bile Duct 
(BD). Hepatocytes showed normal cytoplasm and 
vesicular active nuclei (arrows). Hepatic sinusoids are 
non-congested (Figure 16).
Figure 13.    Normal control group: sections from rat 
liver (portal region) stained by H&E.
Figure 14.    Paracetamol 3000 mg/kg group: sections 
from rat liver (portal region) stained by H&E.
Figure 15.    Captopril 20 mg/kg group: sections from 
rat liver (portal region) stained by H&E. 
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Figure 16.    Captopril 20 mg/kg + Paracetamol 3000 
mg/kg group: sections from rat liver (portal region) 
stained by H&E.
5.  Discussion
Adverse drug reactions are considered serious problems 
worldwide. It is also known that many drugs and toxins can 
cause hepatotoxicity. Paracetamol is an over the counter 
drug that is reported to cause hepatotoxicity if taken in 
overdose14. Paracetamol is metabolized by cytochrome 
P-450 to N-acetyl-p-benzo-quinoneimine (NAPQI). The 
NAPQI causes oxidative stress and glutathione depletion 
in liver cells which leads to hepatotoxicity16,17. Captopril 
is a well-known Angiotensin Converting Enzyme (ACE) 
inhibitor which is considered to be safe with no serious 
side effects. It is generally recommended for the treatment 
of hypertension, congestive heart failure, acute myocardial 
infarction and renal complications of diabetes mellitus18. 
In one of the previous studies captopril is reported to 
enhance total glutathione content as well as glutathione 
peroxidase and glutathione reductase activities in various 
mouse tissues12. However, according to another study 
captopril decreased the activity of both glutathione 
peroxidase and glutathione reductase13 Therefore, it 
was decided to evaluate the histopathological effects of 
captopril using paracetamol induced toxicity model14.
In the present study, when paracetamol was 
administered to rats in low dose of 300 mg/kg for 10 
days and a high single dose of 3000 mg/kg, it produced 
hepatotoxicity as shown in Figure 2 and Figure 10, 
respectively. When captopril 20 mg/kg was administered 
with a low dose of paracetamol 300 mg/kg to rats for 10 
days, it showed marked hepatoprotective effect (Figure 
4). Furthermore, when a dose of captopril 20 mg/kg/
day administered to rats for seven days was followed by 
a single dose of paracetamol 3000 mg/kg, paracetamol 
induced hepatotoxicity was not observed (Figure 12 and 
16).
These results indicate that captopril has 
hepatoprotective effects when evaluated through 
paracetamol induced toxicity model14. This result is in 
line with the study of Elena et al.12 and Nora19, however, 
this result is contradicting the study of Habior
10 and 
Ackerman et al13.
The authors believe that the hepatoprotective effect of 
captopril is because of its sulfhydryl (- SH) group which 
is present in its chemical structure. This group acts as 
a scavenger of oxygen derived free radicals as has been 
reported by Ercument et al20.
6.  Conclusion
In conclusion, from the present study it is evident that 
captopril exerts its hepatoprotective effect in paracetamol 
induced hepatotoxicity model. However to strengthen our 
findings it is recommended to study the hepatoprotective 
effect of captopril using different models.
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